CN Patent

CN104780925A — 用于治疗多发性骨髓瘤的花青素络合物

Assigned to Sapiotec GmbH · Expires 2015-07-15 · 11y expired

What this patent protects

本发明涉及一种飞燕草素和磺烷基醚-β-环糊精的络合物，用作药物，尤其是用于治疗多发性骨髓瘤。

USPTO Abstract

本发明涉及一种飞燕草素和磺烷基醚-β-环糊精的络合物，用作药物，尤其是用于治疗多发性骨髓瘤。

Drugs covered by this patent

Patent Metadata

Patent number
CN104780925A
Jurisdiction
CN
Classification
—
Expires
2015-07-15
Drug substance claim
No
Drug product claim
No
Assignee
Sapiotec GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.